Bellevue Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190M | Sell |
|
|||||
|
2025
Q1 | $197M | Sell |
|
|||||
|
2024
Q4 | $191M | Sell |
|
|||||
|
2024
Q3 | $206M | Sell |
|
|||||
|
2024
Q2 | $198M | Sell |
|
|||||
|
2024
Q1 | $216M | Sell |
|
|||||
|
2023
Q4 | $183M | Buy |
|
|||||
|
2023
Q3 | $140M | Sell |
|
|||||
|
2023
Q2 | $144M | Sell |
|
|||||
|
2023
Q1 | $172M | Sell |
|
|||||
|
2022
Q4 | $181M | Buy |
|
|||||
|
2022
Q3 | $147M | Sell |
|
|||||
|
2022
Q2 | $143M | Sell |
|
|||||
|
2022
Q1 | $173M | Buy |
|
|||||
|
2021
Q4 | $126M | Sell |
|
|||||
|
2021
Q3 | $129M | Buy |
|
|||||
|
2021
Q2 | $99.5M | Hold |
|
|||||
|
2021
Q1 | $89.9M | Buy |
|
|||||
|
2020
Q4 | $79.4M | Buy |
|
|||||
|
2020
Q3 | $72.1M | Buy |
|
|||||
|
2020
Q2 | $60.8M | Buy |
|
|||||
|
2020
Q1 | $50.3M | Sell |
|
|||||
|
2019
Q4 | $71.4M | Buy |
|
|||||
|
2019
Q3 | $57.8M | Buy |
|
|||||
|
2019
Q2 | $59.3M | Buy |
|
|||||
|
2019
Q1 | $44M | Buy |
|
|||||
|
2018
Q4 | $37.4M | Buy |
|
|||||
|
2018
Q3 | $37.7M | Buy |
|
|||||
|
2018
Q2 | $26.8M | Buy |
|
|||||
|
2018
Q1 | $19M | Hold |
|
|||||
|
2017
Q4 | $17.3M | Hold |
|
|||||
|
2017
Q3 | $20.3M | Buy |
|
|||||
|
2017
Q2 | $17.4M | Buy |
|
|||||
|
2017
Q1 | $14.2M | Buy |
|
|||||
|
2016
Q4 | $11.9M | Sell |
|
|||||
|
2016
Q3 | $13.7M | Buy |
|
|||||
|
2016
Q2 | $11.7M | Hold |
|
|||||
|
2016
Q1 | $9.4M | Buy |
|